Ocugen Doses First Patient in Phase 2/3 GARDian3 T...
Category : Clinical Trial Update 23 July 2025Ocugen Inc, a biotech innovator in gene therapies for blindness, has announced a major milestone&mda...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Sun Pharma announces positive phase 3 results eval...
Category : Clinical Trial Update 22 July 2025Overview Sun Pharmaceutical Industries Limited announced top-line results from two phase 3 clinic...
Keros begins patient dosing in phase 3 RENEW trial...
Category : Clinical Trial Update 22 July 2025Overview Keros Therapeutics, Inc. (Keros), a clinical-stage biopharmaceutical company, announced...
AusperBio Receives China CDE Clearance to Advance...
Category : Clinical Trial Update 22 July 2025Overview AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a...
FDA Halts Sarepta Therapeutics’ Elevidys trials fo...
Category : Clinical Trial Update 21 July 2025Overview The US Food and Drug Administration (FDA) announced it has placed Sarepta Therapeutics i...
Latest Newsletter Post
-
Ocugen Doses First Patient in Phase..
23 July 2025
-
AusperBio Receives China CDE Cleara..
22 July 2025
-
Keros begins patient dosing in phas..
22 July 2025
-
Sun Pharma announces positive phase..
22 July 2025
-
Roche provides update on astegolima..
21 July 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com